As of 2025-11-09, the Relative Valuation of 9 Meters Biopharma Inc (NMTR) is (38.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 USD, the upside of 9 Meters Biopharma Inc based on Relative Valuation is -52824.9%.
The range of the Relative Valuation is (36.81) - (38.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.6x - 20.7x | 19.6x |
| Forward P/E multiples | 19.7x - 22.5x | 21.1x |
| Fair Price | (36.81) - (38.76) | (38.07) |
| Upside | -51089.0% - -53783.6% | -52824.9% |
| Date | P/E |